CLPT
ClearPoint Neuro, Inc.
NASDAQ · USHealthcareMedical - Devices
$15.05-0.66%
Price as of Jul 20, 2026
CLPT capital
ClearPoint Neuro, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 3.37x
- Net debt / equity
- 1.49x
- Debt / assets
- 0.68x
- Debt / EBITDA
- -2.69x
- Net debt / EBITDA
- -1.18x
Liquidity & coverage
- Current ratio
- 5.79x
- Quick ratio
- 4.88x
- Cash ratio
- 3.75x
- Interest coverage
- -9.78x
- EBITDA / interest
- -8.74x
- Working capital
- $45.4M
Cash & dividend
- FCF / debt
- -0.42x
- Cash flow / debt
- -0.40x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.